Award
National Institute on Aging 5U01AG076789-03
NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
Recipient
Brigham and Women's Hospital
Award Amount
$857,882.00
Ceiling
$857,882.00
Awarded
August 21, 2024
Identifier
5U01AG076789-03
Research grant awarded to Brigham and Women's Hospital by the National Institute on Aging for a Phase 2a clinical trial on NAD augmentation to treat diabetic kidney disease in older adults.
Description
This is a research grant for a Phase 2a clinical trial investigating NAD augmentation using nicotinamide mononucleotide (NMN) in older adults with diabetic kidney disease. The project is funded by the National Institute on Aging and involves collaboration with Brigham and Women's Hospital in Boston.